Tau Diagnostics and Clinical Studies

Illana Gozes; Günter Höglinger; James P. Quinn; Nigel M. Hooper; Kina Höglund

doi:10.1007/s12031-017-0983-0

Tau Diagnostics and Clinical Studies

Illana Gozes^*, Günter Höglinger, James P. Quinn, Nigel M. Hooper, Kina Höglund

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

50 Downloads (Pure)

Abstract

This short editorial provides our point of view of the first EURO TAU meeting focusing on tau diagnostics and clinical studies. We cover postmortem analyses toward the identification of new biomarkers, tau imaging as a diagnostic biomarker, cerebrospinal fluid (CSF) sampling with emphasis on tau fragments, blood tests and genetic evaluations for sporadic cases, treatment aspects, drug development and points for future developments toward disease modification of devastating tauopathies.

Original language	English
Pages (from-to)	123-130
Number of pages	8
Journal	Journal of Molecular Neuroscience
Volume	63
Issue number	2
Early online date	30 Oct 2017
DOIs	https://doi.org/10.1007/s12031-017-0983-0
Publication status	Published - 2017

Access to Document

10.1007/s12031-017-0983-0

EURO TAU - Tau Diagnostics and clinical studies 28-9-2017Accepted author manuscript, 253 KB

Cite this

@article{b22cabc6ba2148e297f2b864fcf3fd5a,

title = "Tau Diagnostics and Clinical Studies",

abstract = "This short editorial provides our point of view of the first EURO TAU meeting focusing on tau diagnostics and clinical studies. We cover postmortem analyses toward the identification of new biomarkers, tau imaging as a diagnostic biomarker, cerebrospinal fluid (CSF) sampling with emphasis on tau fragments, blood tests and genetic evaluations for sporadic cases, treatment aspects, drug development and points for future developments toward disease modification of devastating tauopathies.",

author = "Illana Gozes and G{\"u}nter H{\"o}glinger and Quinn, {James P.} and Hooper, {Nigel M.} and Kina H{\"o}glund",

year = "2017",

doi = "10.1007/s12031-017-0983-0",

language = "English",

volume = "63",

pages = "123--130",

journal = "Journal of Molecular Neuroscience",

issn = "0895-8696",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - Tau Diagnostics and Clinical Studies

AU - Gozes, Illana

AU - Höglinger, Günter

AU - Quinn, James P.

AU - Hooper, Nigel M.

AU - Höglund, Kina

PY - 2017

Y1 - 2017

N2 - This short editorial provides our point of view of the first EURO TAU meeting focusing on tau diagnostics and clinical studies. We cover postmortem analyses toward the identification of new biomarkers, tau imaging as a diagnostic biomarker, cerebrospinal fluid (CSF) sampling with emphasis on tau fragments, blood tests and genetic evaluations for sporadic cases, treatment aspects, drug development and points for future developments toward disease modification of devastating tauopathies.

AB - This short editorial provides our point of view of the first EURO TAU meeting focusing on tau diagnostics and clinical studies. We cover postmortem analyses toward the identification of new biomarkers, tau imaging as a diagnostic biomarker, cerebrospinal fluid (CSF) sampling with emphasis on tau fragments, blood tests and genetic evaluations for sporadic cases, treatment aspects, drug development and points for future developments toward disease modification of devastating tauopathies.

UR - http://www.scopus.com/inward/record.url?scp=85032506290&partnerID=8YFLogxK

U2 - 10.1007/s12031-017-0983-0

DO - 10.1007/s12031-017-0983-0

M3 - Editorial

AN - SCOPUS:85032506290

SN - 0895-8696

VL - 63

SP - 123

EP - 130

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

IS - 2

ER -

Tau Diagnostics and Clinical Studies

Abstract

Access to Document

Other files and links

Fingerprint

Cite this